---
title: "Weekly Recap | Cameco -0.8%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305533478.md"
description: "Cameco (CCJ) closed at $70.73, down 0.8% from Friday’s $71.30. The S&P 500 gained 2.51% over the same stretch, leaving the stock about 3.31 percentage points behind the benchmark. Monday saw an intraday high of $75.605, followed by a steady drift lower through the week. Friday’s low was $70.01, and the weekly range came to 7.62%."
datetime: "2026-11-14T06:08:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305533478.md)
  - [en](https://longbridge.com/en/news/305533478.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305533478.md)
generator: "portal-rs"
---

# Weekly Recap | Cameco -0.8%, most brokers rate it buy

## The Week

Cameco (CCJ) closed at $70.73, down 0.8% from Friday’s $71.30. The S&P 500 gained 2.51% over the same stretch, leaving the stock about 3.31 percentage points behind the benchmark. Monday saw an intraday high of $75.605, followed by a steady drift lower through the week. Friday’s low was $70.01, and the weekly range came to 7.62%.

## Key Events

Most of the week’s coverage framed Cameco within the broader Canadian nuclear theme. Monday brought a report highlighting CCJ alongside AtkinsRéalis Group, plus a note that some call options had soared 300% after a 4% rally the previous Friday. The same day, a list of three Canadian nuclear stocks to own in November 2026 included CCJ. Tuesday saw a brief intraday gain of nearly 6%. Thursday’s coverage again grouped Cameco with two other Canadian growth stocks. The company itself released no earnings or major announcements this week.

## Analyst Ratings

Across 21 covering firms, 12 rate Cameco buy, 7 rate it overweight and 2 rate it hold; none rate it underweight or sell. The consensus recommendation is buy, with a consensus target of $117.80, roughly 66.6% above the latest close. Individual targets range from $83.76 to $172.21, a wide spread. Within the coal and consumable fuels industry, Cameco ranks first among 16 names, where the average firm count is 8.

## The Week Ahead

On the macro side, the New York Fed manufacturing index lands on Monday with a forecast of 18 versus a prior 25.5. Tuesday brings retail sales, retail sales ex-autos, industrial production and import prices. Cameco’s fiscal Q4 2026 earnings are not due until 12 February 2027, before market open. There are no company-specific events on next week’s calendar.

## In Short

The week’s signals are mixed. Coverage is heavily buy-rated, with a consensus target about two-thirds above spot and an industry rank of first. Yet the stock faded while the broader market rose, and the P/E sits near 108x. Latest-session flows show small and mid-lot net buying against large-lot net selling. The question going forward is whether the nuclear theme holds enough heat, and whether fiscal Q4 results can support the current valuation.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [CCJ.US](https://longbridge.com/en/quote/CCJ.US.md)

## Related News & Research

- [Can Cameco (TSX:CCO) Justify Its Price After The $1b ATM?](https://longbridge.com/en/news/305813188.md)
- [CCO: Q3 earnings softened, but tighter guidance and nuclear fundamentals support the long-term outlook](https://longbridge.com/en/news/303734959.md)
- [Uranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?](https://longbridge.com/en/news/303969217.md)
- [Nasdaq (NDAQ) Just Gave Investors Something To Think About](https://longbridge.com/en/news/306370324.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**